These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1932374

  • 21. Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha.
    Shinozuka H, Ohmura T, Katyal SL, Zedda AI, Ledda-Columbano GM, Columbano A.
    Hepatology; 1996 Jun; 23(6):1572-7. PubMed ID: 8675179
    [Abstract] [Full Text] [Related]

  • 22. Studies on tumor necrosis factor (TNF): II. Metabolic fate and distribution of human recombinant TNF.
    Pessina GP, Pacini A, Bocci V, Maioli E, Naldini A.
    Lymphokine Res; 1987 Jun; 6(1):35-44. PubMed ID: 3821169
    [Abstract] [Full Text] [Related]

  • 23. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
    Adamson GM, Billings RE.
    J Pharmacol Exp Ther; 1994 Apr; 269(1):367-73. PubMed ID: 8169842
    [Abstract] [Full Text] [Related]

  • 24. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ, Falcioni R, Wesley JW.
    Cancer Res; 1991 Mar 01; 51(5):1529-36. PubMed ID: 1997194
    [Abstract] [Full Text] [Related]

  • 25. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
    Yamada S, Ohkura T, Deguchi Y, Kimura R.
    J Pharmacol Exp Ther; 1999 Jun 01; 289(3):1575-83. PubMed ID: 10336555
    [Abstract] [Full Text] [Related]

  • 26. Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo.
    Klapproth J, Castell J, Geiger T, Andus T, Heinrich PC.
    Eur J Immunol; 1989 Aug 01; 19(8):1485-90. PubMed ID: 2476319
    [Abstract] [Full Text] [Related]

  • 27. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A.
    Arzneimittelforschung; 1992 Apr 01; 42(4):579-84. PubMed ID: 1642686
    [Abstract] [Full Text] [Related]

  • 28. Clearance and metabolism of 125I-labeled tonin in the rat.
    Morris BJ, Cheng ES.
    Endocrinology; 1982 Nov 01; 111(5):1462-8. PubMed ID: 6181985
    [Abstract] [Full Text] [Related]

  • 29. Radioimmunoassay for bovine tumor necrosis factor: concentrations and circulating molecular forms in bovine plasma.
    Kenison DC, Elsasser TH, Fayer R.
    J Immunoassay; 1990 Nov 01; 11(2):177-98. PubMed ID: 2112161
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-6 tumor necrosis factor-alpha clearance and metabolism in vivo and by the isolated, perfused liver in the rat: effect of acute alcohol administration.
    Deaciuc IV, Alappat JM, McDonough KH, D'Souza NB.
    Alcohol Clin Exp Res; 1996 Apr 01; 20(2):293-301. PubMed ID: 8730220
    [Abstract] [Full Text] [Related]

  • 31. Clearance of [125I]-tumor necrosis factor-alpha from the brain into the blood after intracerebroventricular injection in rats.
    Chen G, Reichlin S.
    Neuroimmunomodulation; 1998 Apr 01; 5(5):261-9. PubMed ID: 9730694
    [Abstract] [Full Text] [Related]

  • 32. The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats.
    Reimers J, Wogensen LD, Welinder B, Hejnaes KR, Poulsen SS, Nilsson P, Nerup J.
    Scand J Immunol; 1991 Nov 01; 34(5):597-610. PubMed ID: 1947795
    [Abstract] [Full Text] [Related]

  • 33. Disposition of 125I-labeled recombinant human tumor necrosis factor in the tumor-bearing mouse.
    Miyazaki H, Fujii T, Amejima H, Mikuriya N, Nambu K, Kagemoto A, Nakao M, Oh-e Y, Matsumoto K, Matsui Y.
    Biotherapy; 1988 Nov 01; 1(1):7-18. PubMed ID: 3079460
    [Abstract] [Full Text] [Related]

  • 34. The in vivo metabolism of recombinant human erythropoietin in the rat.
    Spivak JL, Hogans BB.
    Blood; 1989 Jan 01; 73(1):90-9. PubMed ID: 2462945
    [Abstract] [Full Text] [Related]

  • 35. Nutrition support affects the distribution and organ uptake of cachectin/tumor necrosis factor in rats.
    Keith ME, Norwich KH, Jeejeebhoy KN.
    JPEN J Parenter Enteral Nutr; 1995 Jan 01; 19(5):341-50. PubMed ID: 8577009
    [Abstract] [Full Text] [Related]

  • 36. Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats.
    van der Veen AH, Eggermont AM, Seynhaeve AL, van Tiel, ten Hagen TL.
    Int J Cancer; 1998 Sep 11; 77(6):901-6. PubMed ID: 9714061
    [Abstract] [Full Text] [Related]

  • 37. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin.
    Rucinski B, Knight LC, Niewiarowski S.
    Am J Physiol; 1986 Oct 11; 251(4 Pt 2):H800-7. PubMed ID: 3766757
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.
    Zioncheck TF, Chen SA, Richardson L, Mora-Worms M, Lucas C, Lewis D, Green JD, Mordenti J.
    Pharm Res; 1994 Feb 11; 11(2):213-20. PubMed ID: 8165178
    [Abstract] [Full Text] [Related]

  • 39. Studies on tumor necrosis factor (TNF). III. Plasma disappearance curves after intramuscular, subcutaneous, intraperitoneal, and oral administration of human recombinant TNF.
    Pacini A, Maioli E, Bocci V, Pessina GP.
    Cancer Drug Deliv; 1987 Feb 11; 4(1):17-23. PubMed ID: 3607720
    [Abstract] [Full Text] [Related]

  • 40. Studies on the disappearance of equine chorionic gonadotropin from the circulation in the rat: tissue uptake and degradation.
    Aggarwal BB, Papkoff H.
    Endocrinology; 1981 Oct 11; 109(4):1242-7. PubMed ID: 7285870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.